Skip to main content

Address

Panerių g. 246
48454 Kaunas
Lithuania

Opening hours

  • Mon – Fri
    9 :00 – 17 00
  • Sat
    Closed    
  • Sun
    Closed   
Dog DNA testing illustration

Pug Dog Encephalitis (PDE) / Necrotizing Meningoencephalitis (NME) Risk Factor

Code: H143

74,72 €

Sample details

One test – one sample. Animal and owner details are optional.

Search by our number or the laboratory number. An unmatched number is saved as a previous / external reference. No new physical sample is needed.
The add to cart button will appear once you select the values above

Short description

Pug Dog Encephalitis (PDE), also known as Necrotizing Meningoencephalitis (NME), is a severe neurological condition primarily affecting Pugs, though it has also been reported in other small breeds, such as the Maltese, Chihuahua, and Yorkshire Terrier.

General information

Pug Dog Encephalitis (PDE), also known as Necrotizing Meningoencephalitis (NME), is a severe neurological condition primarily affecting Pugs, though it has also been reported in other small breeds, such as the Maltese, Chihuahua, and Yorkshire Terrier. PDE is an autoimmune disease characterized by inflammation in the brain, leading to neurological symptoms. The condition is usually progressive and fatal. While the exact genetic cause is not fully understood, this test analyses a specific mutation in the Dog Leukocyte Antigen (DLA) gene associated with increased risk. This test is not a diagnostic tool but serves as risk factor.

Specifications

Breeds

Pug

Gene

DLA-DPB1

Organ

Nervous System

Specimen

Copan eNAT swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Autosomal Recessive with incomplete penetrance

Chromosome

12

Also known as

NME, PDE

Year Published

2018

Clinical features

PDE most commonly affects Pugs between 1 and 6 years of age. The onset can be sudden, with symptoms progressing rapidly. Clinical signs include seizures, circling, tremors, vision loss, disorientation, and changes in behaviour. The disease often leads to death within weeks to months after onset or euthanazia is chosen as a humane-endpoint. Especially as treatment in dogs rarely lead to long-term survival.

Additional information

The genetic marker tested is considered to be a risk factor. It is associated with the disorder, but does not necessarily guarantee it. Dogs that are homozygous for the mutation (2 copies) have a higher chance of developing PDE compared to dogs that are heterozygous or lack the mutation.

References

Pubmed ID: 38840637

Omia ID: 1470

Turnaround information

  • 15 working days